

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid transmembrane transport (GO:1902001) | 9.60447943 |
| 2 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 8.97505040 |
| 3 | tricarboxylic acid cycle (GO:0006099) | 8.91428606 |
| 4 | biotin metabolic process (GO:0006768) | 8.82270447 |
| 5 | NADH metabolic process (GO:0006734) | 8.58849918 |
| 6 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 8.24490205 |
| 7 | carnitine transmembrane transport (GO:1902603) | 8.14187438 |
| 8 | regulation of fatty acid oxidation (GO:0046320) | 7.99179663 |
| 9 | fatty acid beta-oxidation (GO:0006635) | 7.77439385 |
| 10 | regulation of cofactor metabolic process (GO:0051193) | 7.76741588 |
| 11 | regulation of coenzyme metabolic process (GO:0051196) | 7.76741588 |
| 12 | diacylglycerol metabolic process (GO:0046339) | 7.56774929 |
| 13 | amino-acid betaine transport (GO:0015838) | 7.48935659 |
| 14 | carnitine transport (GO:0015879) | 7.48935659 |
| 15 | positive regulation of fatty acid oxidation (GO:0046321) | 6.96787238 |
| 16 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 6.90019354 |
| 17 | fatty acid catabolic process (GO:0009062) | 6.50882770 |
| 18 | fatty acid oxidation (GO:0019395) | 6.48945815 |
| 19 | lipid oxidation (GO:0034440) | 6.38310817 |
| 20 | acetyl-CoA metabolic process (GO:0006084) | 6.34898955 |
| 21 | linoleic acid metabolic process (GO:0043651) | 6.28464238 |
| 22 | regulation of sulfur metabolic process (GO:0042762) | 6.21962152 |
| 23 | plasma lipoprotein particle clearance (GO:0034381) | 5.99757501 |
| 24 | intracellular lipid transport (GO:0032365) | 5.87287927 |
| 25 | phospholipid homeostasis (GO:0055091) | 5.84166656 |
| 26 | L-serine transport (GO:0015825) | 5.81052233 |
| 27 | thioester biosynthetic process (GO:0035384) | 5.79585788 |
| 28 | acyl-CoA biosynthetic process (GO:0071616) | 5.79585788 |
| 29 | succinate metabolic process (GO:0006105) | 5.73999451 |
| 30 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 5.67893527 |
| 31 | coenzyme A biosynthetic process (GO:0015937) | 5.61451894 |
| 32 | triglyceride catabolic process (GO:0019433) | 5.60450041 |
| 33 | quaternary ammonium group transport (GO:0015697) | 5.52782297 |
| 34 | regulation of fatty acid beta-oxidation (GO:0031998) | 5.47285556 |
| 35 | branched-chain amino acid catabolic process (GO:0009083) | 5.45191245 |
| 36 | triglyceride biosynthetic process (GO:0019432) | 5.32164301 |
| 37 | white fat cell differentiation (GO:0050872) | 5.25429052 |
| 38 | lipid particle organization (GO:0034389) | 5.23627825 |
| 39 | lipid storage (GO:0019915) | 5.23341179 |
| 40 | CDP-diacylglycerol metabolic process (GO:0046341) | 5.19790121 |
| 41 | neutral lipid catabolic process (GO:0046461) | 5.10260349 |
| 42 | acylglycerol catabolic process (GO:0046464) | 5.10260349 |
| 43 | acylglycerol biosynthetic process (GO:0046463) | 5.07864025 |
| 44 | neutral lipid biosynthetic process (GO:0046460) | 5.07864025 |
| 45 | regulation of glycogen (starch) synthase activity (GO:2000465) | 5.06258447 |
| 46 | lysine catabolic process (GO:0006554) | 5.05675594 |
| 47 | lysine metabolic process (GO:0006553) | 5.05675594 |
| 48 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 5.05562295 |
| 49 | proline transport (GO:0015824) | 5.04516671 |
| 50 | tricarboxylic acid metabolic process (GO:0072350) | 5.02305253 |
| 51 | serine transport (GO:0032329) | 5.01838908 |
| 52 | glycine transport (GO:0015816) | 4.97673174 |
| 53 | monocarboxylic acid catabolic process (GO:0072329) | 4.96768240 |
| 54 | valine metabolic process (GO:0006573) | 4.93348090 |
| 55 | * brown fat cell differentiation (GO:0050873) | 4.89905929 |
| 56 | positive regulation of cholesterol efflux (GO:0010875) | 4.88671409 |
| 57 | short-chain fatty acid metabolic process (GO:0046459) | 4.88503864 |
| 58 | positive regulation of lipid storage (GO:0010884) | 4.85728371 |
| 59 | branched-chain amino acid metabolic process (GO:0009081) | 4.85406275 |
| 60 | regulation of triglyceride catabolic process (GO:0010896) | 4.80671892 |
| 61 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.75171790 |
| 62 | cardiolipin metabolic process (GO:0032048) | 4.64291779 |
| 63 | alanine transport (GO:0032328) | 4.62798084 |
| 64 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.62558213 |
| 65 | carnitine metabolic process (GO:0009437) | 4.61141854 |
| 66 | low-density lipoprotein particle clearance (GO:0034383) | 4.59749806 |
| 67 | ethanol oxidation (GO:0006069) | 4.54464536 |
| 68 | coenzyme A metabolic process (GO:0015936) | 4.49249920 |
| 69 | glycerol metabolic process (GO:0006071) | 4.45302451 |
| 70 | regulation of cholesterol storage (GO:0010885) | 4.39725928 |
| 71 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.37199946 |
| 72 | oxaloacetate metabolic process (GO:0006107) | 4.35763867 |
| 73 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 4.34884082 |
| 74 | retinol metabolic process (GO:0042572) | 4.34487645 |
| 75 | positive regulation of lipid catabolic process (GO:0050996) | 4.33711759 |
| 76 | negative regulation of fatty acid metabolic process (GO:0045922) | 4.31572230 |
| 77 | positive regulation of cholesterol transport (GO:0032376) | 4.29026072 |
| 78 | positive regulation of sterol transport (GO:0032373) | 4.29026072 |
| 79 | acyl-CoA metabolic process (GO:0006637) | 4.24103694 |
| 80 | thioester metabolic process (GO:0035383) | 4.24103694 |
| 81 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.21530120 |
| 82 | response to gravity (GO:0009629) | 4.15285343 |
| 83 | primary alcohol metabolic process (GO:0034308) | 4.12055236 |
| 84 | regulation of fatty acid metabolic process (GO:0019217) | 4.10503636 |
| 85 | long-chain fatty acid transport (GO:0015909) | 4.05374623 |
| 86 | phosphatidic acid metabolic process (GO:0046473) | 4.01518506 |
| 87 | phosphatidic acid biosynthetic process (GO:0006654) | 4.01518506 |
| 88 | positive regulation of glycolytic process (GO:0045821) | 4.00866002 |
| 89 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.95358415 |
| 90 | alditol metabolic process (GO:0019400) | 3.89617799 |
| 91 | coenzyme catabolic process (GO:0009109) | 3.87201482 |
| 92 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.86197459 |
| 93 | regulation of lipid storage (GO:0010883) | 3.85358582 |
| 94 | glycerolipid catabolic process (GO:0046503) | 3.81651808 |
| 95 | negative regulation of lipid storage (GO:0010888) | 3.80190826 |
| 96 | cellular lipid catabolic process (GO:0044242) | 3.80032509 |
| 97 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.72627374 |
| 98 | cellular response to lithium ion (GO:0071285) | 3.72480047 |
| 99 | ethanol metabolic process (GO:0006067) | 3.71143857 |
| 100 | triglyceride metabolic process (GO:0006641) | 3.70491078 |
| 101 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.70033884 |
| 102 | * respiratory electron transport chain (GO:0022904) | 3.68980285 |
| 103 | regulation of triglyceride metabolic process (GO:0090207) | 3.67485426 |
| 104 | negative regulation of lipid catabolic process (GO:0050995) | 3.64636345 |
| 105 | temperature homeostasis (GO:0001659) | 3.63812784 |
| 106 | * electron transport chain (GO:0022900) | 3.59185505 |
| 107 | fatty acid elongation (GO:0030497) | 3.56478591 |
| 108 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.54803379 |
| 109 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.54744757 |
| 110 | acylglycerol metabolic process (GO:0006639) | 3.51016754 |
| 111 | peroxisome fission (GO:0016559) | 3.50986756 |
| 112 | regulation of lipid catabolic process (GO:0050994) | 3.50325581 |
| 113 | pentose-phosphate shunt (GO:0006098) | 3.49114428 |
| 114 | cholesterol biosynthetic process (GO:0006695) | 3.48422102 |
| 115 | amino-acid betaine metabolic process (GO:0006577) | 3.47405495 |
| 116 | response to phenylpropanoid (GO:0080184) | 3.46832617 |
| 117 | neutral lipid metabolic process (GO:0006638) | 3.46542259 |
| 118 | fatty acid transport (GO:0015908) | 3.45180009 |
| 119 | regulation of cholesterol efflux (GO:0010874) | 3.42814415 |
| 120 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 3.42583497 |
| 121 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 3.42583497 |
| 122 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 3.42583497 |
| 123 | triglyceride homeostasis (GO:0070328) | 3.42009649 |
| 124 | acylglycerol homeostasis (GO:0055090) | 3.42009649 |
| 125 | protein heterotrimerization (GO:0070208) | 3.41263408 |
| 126 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.39250680 |
| 127 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.38876292 |
| 128 | positive regulation of glomerulus development (GO:0090193) | 3.38540904 |
| 129 | cellular response to epinephrine stimulus (GO:0071872) | 3.37227356 |
| 130 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.36120070 |
| 131 | regulation of cholesterol metabolic process (GO:0090181) | 3.35472071 |
| 132 | NADPH regeneration (GO:0006740) | 3.34197627 |
| 133 | aspartate family amino acid catabolic process (GO:0009068) | 3.31613643 |
| 134 | pantothenate metabolic process (GO:0015939) | 3.31161402 |
| 135 | alpha-linolenic acid metabolic process (GO:0036109) | 3.28564231 |
| 136 | negative regulation of lipase activity (GO:0060192) | 3.26818158 |
| 137 | very long-chain fatty acid metabolic process (GO:0000038) | 3.22546916 |
| 138 | negative regulation of metanephros development (GO:0072217) | 3.21795984 |
| 139 | sterol biosynthetic process (GO:0016126) | 3.10071616 |
| 140 | negative regulation of macrophage differentiation (GO:0045650) | 3.09710845 |
| 141 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.03132621 |
| 142 | regulation of sequestering of triglyceride (GO:0010889) | 11.3696751 |
| 143 | fatty acid homeostasis (GO:0055089) | 11.0454360 |
| 144 | carnitine shuttle (GO:0006853) | 10.5924820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 8.24017407 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.09064651 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.04371707 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.78480688 |
| 5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.35764584 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.25736212 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.04183353 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.61345408 |
| 9 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.55995542 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.45909526 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.32977812 |
| 12 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.16705604 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.14454347 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.03227491 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.02135495 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.01015021 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 16.0985590 |
| 18 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.96766512 |
| 19 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.89113434 |
| 20 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.69463113 |
| 21 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.68145147 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.63773618 |
| 23 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.54742710 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.47107577 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.41041325 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.36258023 |
| 27 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.32204288 |
| 28 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.30508429 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.29424052 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.28165771 |
| 31 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27793101 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.26592346 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24946045 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.23885688 |
| 35 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.22060308 |
| 36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21882718 |
| 37 | RXR_22108803_ChIP-Seq_LS180_Human | 1.17796805 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17694653 |
| 39 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17411603 |
| 40 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14086863 |
| 41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.13545153 |
| 42 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12263558 |
| 43 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.06386144 |
| 44 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.06327801 |
| 45 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.06327801 |
| 46 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.04563761 |
| 47 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.04563761 |
| 48 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.02742818 |
| 49 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01560304 |
| 50 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97178579 |
| 51 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.96109159 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95755684 |
| 53 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.94848187 |
| 54 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93813717 |
| 55 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.92931095 |
| 56 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.92931095 |
| 57 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.92796471 |
| 58 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.92576397 |
| 59 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.92506035 |
| 60 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.91642409 |
| 61 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.91610512 |
| 62 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.91441014 |
| 63 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.90969622 |
| 64 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.88956559 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 0.88708064 |
| 66 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.87982723 |
| 67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87230516 |
| 68 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.87075185 |
| 69 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.86468836 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.86403990 |
| 71 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.86140135 |
| 72 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.84919539 |
| 73 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.84175729 |
| 74 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.83207786 |
| 75 | CBP_21632823_ChIP-Seq_H3396_Human | 0.83089987 |
| 76 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.81937552 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81681430 |
| 78 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.81553839 |
| 79 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81484258 |
| 80 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.81428844 |
| 81 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.77879441 |
| 82 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.75837584 |
| 83 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.75667625 |
| 84 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75419312 |
| 85 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.74108791 |
| 86 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.73908460 |
| 87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.73832858 |
| 88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.71371571 |
| 89 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.71264630 |
| 90 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.71001965 |
| 91 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.69982215 |
| 92 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.69965706 |
| 93 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.69007333 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.68919013 |
| 95 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.68212613 |
| 96 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.65961721 |
| 97 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.65932320 |
| 98 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.65448418 |
| 99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.64747781 |
| 100 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.64550764 |
| 101 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.63701280 |
| 102 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63401779 |
| 103 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.63095249 |
| 104 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.62903535 |
| 105 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62720993 |
| 106 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.62644181 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60704786 |
| 108 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.60185103 |
| 109 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.60140918 |
| 110 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.59874211 |
| 111 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.59636174 |
| 112 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.58939007 |
| 113 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.58701566 |
| 114 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.57499914 |
| 115 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.57424728 |
| 116 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.56912554 |
| 117 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.55700743 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.55274574 |
| 119 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.55195777 |
| 120 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.54900454 |
| 121 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.54424726 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.54220167 |
| 123 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.53777863 |
| 124 | ATF3_27146783_Chip-Seq_COLON_Human | 0.53639361 |
| 125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.53479564 |
| 126 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.53479564 |
| 127 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.53261383 |
| 128 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.52865383 |
| 129 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.51814471 |
| 130 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.50899489 |
| 131 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.50613992 |
| 132 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.50206520 |
| 133 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.50103411 |
| 134 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49904346 |
| 135 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.49159756 |
| 136 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.48410588 |
| 137 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.47755767 |
| 138 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.47092357 |
| 139 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.46481909 |
| 140 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.46345298 |
| 141 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.46316221 |
| 142 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.46193386 |
| 143 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.45785887 |
| 144 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.45009279 |
| 145 | * ERG_20517297_ChIP-Seq_VCAP_Human | 0.44701330 |
| 146 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.43884915 |
| 147 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.43330795 |
| 148 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.42606975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 8.85600525 |
| 2 | MP0005666_abnormal_adipose_tissue | 6.31588498 |
| 3 | MP0004130_abnormal_muscle_cell | 5.32983256 |
| 4 | MP0004185_abnormal_adipocyte_glucose | 4.97434218 |
| 5 | * MP0002971_abnormal_brown_adipose | 4.62259501 |
| 6 | MP0005375_adipose_tissue_phenotype | 4.12879882 |
| 7 | MP0003646_muscle_fatigue | 3.81578564 |
| 8 | * MP0005535_abnormal_body_temperature | 3.10020603 |
| 9 | MP0009840_abnormal_foam_cell | 2.96838149 |
| 10 | MP0003011_delayed_dark_adaptation | 2.91165350 |
| 11 | MP0000003_abnormal_adipose_tissue | 2.75514213 |
| 12 | MP0000013_abnormal_adipose_tissue | 2.74649578 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.70286527 |
| 14 | MP0009115_abnormal_fat_cell | 2.59882330 |
| 15 | * MP0006036_abnormal_mitochondrial_physio | 2.59550613 |
| 16 | MP0005334_abnormal_fat_pad | 2.45669584 |
| 17 | * MP0002970_abnormal_white_adipose | 2.38475684 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.35983875 |
| 19 | * MP0002118_abnormal_lipid_homeostasis | 2.34590238 |
| 20 | MP0008438_abnormal_cutaneous_collagen | 2.11636552 |
| 21 | MP0005330_cardiomyopathy | 2.02066494 |
| 22 | MP0005332_abnormal_amino_acid | 1.98634018 |
| 23 | MP0002078_abnormal_glucose_homeostasis | 1.93208169 |
| 24 | MP0003868_abnormal_feces_composition | 1.84699286 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.83435803 |
| 26 | MP0009672_abnormal_birth_weight | 1.71728480 |
| 27 | MP0008961_abnormal_basal_metabolism | 1.71523668 |
| 28 | MP0000609_abnormal_liver_physiology | 1.62518654 |
| 29 | MP0002332_abnormal_exercise_endurance | 1.60992514 |
| 30 | MP0003828_pulmonary_edema | 1.55739045 |
| 31 | MP0003724_increased_susceptibility_to | 1.54425567 |
| 32 | MP0001661_extended_life_span | 1.53493615 |
| 33 | MP0005365_abnormal_bile_salt | 1.53486705 |
| 34 | * MP0005452_abnormal_adipose_tissue | 1.48623734 |
| 35 | MP0008775_abnormal_heart_ventricle | 1.42370953 |
| 36 | MP0003283_abnormal_digestive_organ | 1.37675800 |
| 37 | MP0003221_abnormal_cardiomyocyte_apopto | 1.36422447 |
| 38 | * MP0005448_abnormal_energy_balance | 1.33959282 |
| 39 | MP0003959_abnormal_lean_body | 1.33604846 |
| 40 | MP0006138_congestive_heart_failure | 1.31942048 |
| 41 | MP0006035_abnormal_mitochondrial_morpho | 1.30203023 |
| 42 | MP0005275_abnormal_skin_tensile | 1.27912231 |
| 43 | MP0004087_abnormal_muscle_fiber | 1.27801013 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.22953158 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.22088047 |
| 46 | MP0004782_abnormal_surfactant_physiolog | 1.16379867 |
| 47 | MP0005385_cardiovascular_system_phenoty | 1.14481752 |
| 48 | MP0001544_abnormal_cardiovascular_syste | 1.14481752 |
| 49 | MP0003690_abnormal_glial_cell | 1.11961262 |
| 50 | MP0001177_atelectasis | 1.10701602 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.09840742 |
| 52 | MP0005647_abnormal_sex_gland | 1.06398061 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.00116958 |
| 54 | MP0010630_abnormal_cardiac_muscle | 0.99977801 |
| 55 | MP0004043_abnormal_pH_regulation | 0.98057633 |
| 56 | MP0001879_abnormal_lymphatic_vessel | 0.97901222 |
| 57 | MP0004272_abnormal_basement_membrane | 0.95854527 |
| 58 | MP0009703_decreased_birth_body | 0.93469188 |
| 59 | MP0000759_abnormal_skeletal_muscle | 0.92517174 |
| 60 | MP0001853_heart_inflammation | 0.89627760 |
| 61 | MP0005620_abnormal_muscle_contractility | 0.86293945 |
| 62 | MP0000343_altered_response_to | 0.85730503 |
| 63 | * MP0003953_abnormal_hormone_level | 0.85016452 |
| 64 | MP0003705_abnormal_hypodermis_morpholog | 0.84840489 |
| 65 | MP0001529_abnormal_vocalization | 0.83908840 |
| 66 | MP0002972_abnormal_cardiac_muscle | 0.83438028 |
| 67 | MP0004233_abnormal_muscle_weight | 0.82131277 |
| 68 | MP0003137_abnormal_impulse_conducting | 0.81571333 |
| 69 | MP0003329_amyloid_beta_deposits | 0.76725267 |
| 70 | MP0002796_impaired_skin_barrier | 0.76573250 |
| 71 | MP0003195_calcinosis | 0.75964895 |
| 72 | * MP0003948_abnormal_gas_homeostasis | 0.75264154 |
| 73 | MP0003186_abnormal_redox_activity | 0.73156051 |
| 74 | MP0004215_abnormal_myocardial_fiber | 0.72043319 |
| 75 | MP0009643_abnormal_urine_homeostasis | 0.71932263 |
| 76 | MP0002139_abnormal_hepatobiliary_system | 0.69612841 |
| 77 | MP0003566_abnormal_cell_adhesion | 0.69350544 |
| 78 | MP0004742_abnormal_vestibular_system | 0.69333951 |
| 79 | MP0003950_abnormal_plasma_membrane | 0.68118032 |
| 80 | MP0005085_abnormal_gallbladder_physiolo | 0.67796738 |
| 81 | MP0001727_abnormal_embryo_implantation | 0.66855092 |
| 82 | MP0000604_amyloidosis | 0.66770042 |
| 83 | MP0005164_abnormal_response_to | 0.66543429 |
| 84 | MP0000749_muscle_degeneration | 0.66317104 |
| 85 | MP0001881_abnormal_mammary_gland | 0.66244364 |
| 86 | MP0003045_fibrosis | 0.65984441 |
| 87 | MP0005646_abnormal_pituitary_gland | 0.65815851 |
| 88 | MP0000230_abnormal_systemic_arterial | 0.64311166 |
| 89 | MP0004484_altered_response_of | 0.64094611 |
| 90 | MP0003300_gastrointestinal_ulcer | 0.63365831 |
| 91 | MP0001440_abnormal_grooming_behavior | 0.63313149 |
| 92 | MP0005083_abnormal_biliary_tract | 0.62626417 |
| 93 | MP0002133_abnormal_respiratory_system | 0.62372888 |
| 94 | MP0005388_respiratory_system_phenotype | 0.62372888 |
| 95 | MP0000751_myopathy | 0.61908691 |
| 96 | MP0002106_abnormal_muscle_physiology | 0.58396898 |
| 97 | MP0005386_behavior/neurological_phenoty | 0.58251097 |
| 98 | MP0004924_abnormal_behavior | 0.58251097 |
| 99 | MP0009780_abnormal_chondrocyte_physiolo | 0.57781067 |
| 100 | MP0001764_abnormal_homeostasis | 0.56873244 |
| 101 | MP0005266_abnormal_metabolism | 0.56248131 |
| 102 | MP0001756_abnormal_urination | 0.55875930 |
| 103 | MP0004036_abnormal_muscle_relaxation | 0.55108320 |
| 104 | MP0000750_abnormal_muscle_regeneration | 0.50502858 |
| 105 | MP0002638_abnormal_pupillary_reflex | 0.50427311 |
| 106 | MP0002102_abnormal_ear_morphology | 0.50267294 |
| 107 | MP0005376_homeostasis/metabolism_phenot | 0.48648638 |
| 108 | MP0002909_abnormal_adrenal_gland | 0.48479935 |
| 109 | MP0005076_abnormal_cell_differentiation | 0.48345013 |
| 110 | MP0000767_abnormal_smooth_muscle | 0.48146572 |
| 111 | MP0002069_abnormal_eating/drinking_beha | 0.48129722 |
| 112 | MP0002060_abnormal_skin_morphology | 0.46718919 |
| 113 | * MP0009642_abnormal_blood_homeostasis | 0.46484286 |
| 114 | MP0002269_muscular_atrophy | 0.46364633 |
| 115 | MP0000372_irregular_coat_pigmentation | 0.45796044 |
| 116 | MP0005595_abnormal_vascular_smooth | 0.45111944 |
| 117 | MP0000598_abnormal_liver_morphology | 0.45033344 |
| 118 | MP0001984_abnormal_olfaction | 0.44490396 |
| 119 | MP0002166_altered_tumor_susceptibility | 0.43788966 |
| 120 | MP0003942_abnormal_urinary_system | 0.42213075 |
| 121 | MP0004085_abnormal_heartbeat | 0.41645397 |
| 122 | MP0000747_muscle_weakness | 0.41307152 |
| 123 | MP0010030_abnormal_orbit_morphology | 0.41126458 |
| 124 | MP0001944_abnormal_pancreas_morphology | 0.40529323 |
| 125 | MP0002876_abnormal_thyroid_physiology | 0.40501952 |
| 126 | MP0003879_abnormal_hair_cell | 0.40384458 |
| 127 | MP0002168_other_aberrant_phenotype | 0.40359355 |
| 128 | MP0000534_abnormal_ureter_morphology | 0.40064848 |
| 129 | MP0009763_increased_sensitivity_to | 0.39693314 |
| 130 | MP0005369_muscle_phenotype | 0.39421710 |
| 131 | MP0004084_abnormal_cardiac_muscle | 0.39131566 |
| 132 | MP0003279_aneurysm | 0.38399587 |
| 133 | MP0002877_abnormal_melanocyte_morpholog | 0.37986365 |
| 134 | MP0006276_abnormal_autonomic_nervous | 0.37958636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 7.45699947 |
| 2 | Myoglobinuria (HP:0002913) | 6.90245486 |
| 3 | Hypoglycemic coma (HP:0001325) | 6.75440801 |
| 4 | Abnormality of fatty-acid metabolism (HP:0004359) | 6.57264476 |
| 5 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 6.32583942 |
| 6 | Dicarboxylic aciduria (HP:0003215) | 6.32583942 |
| 7 | Rhabdomyolysis (HP:0003201) | 6.27773971 |
| 8 | Abnormality of glycine metabolism (HP:0010895) | 5.84971616 |
| 9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.84971616 |
| 10 | Hepatic necrosis (HP:0002605) | 5.50254483 |
| 11 | Increased muscle lipid content (HP:0009058) | 5.31869783 |
| 12 | Hydroxyprolinuria (HP:0003080) | 4.82135211 |
| 13 | Abnormality of proline metabolism (HP:0010907) | 4.82135211 |
| 14 | Generalized aminoaciduria (HP:0002909) | 4.81909337 |
| 15 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.66421335 |
| 16 | Hyperammonemia (HP:0001987) | 4.48808590 |
| 17 | Oligomenorrhea (HP:0000876) | 4.44489135 |
| 18 | Hyperlipoproteinemia (HP:0010980) | 4.25866091 |
| 19 | Renal cortical cysts (HP:0000803) | 4.22449202 |
| 20 | Ketoacidosis (HP:0001993) | 4.20424401 |
| 21 | Xanthomatosis (HP:0000991) | 4.17739351 |
| 22 | Epidermoid cyst (HP:0200040) | 3.97034095 |
| 23 | Potter facies (HP:0002009) | 3.90012607 |
| 24 | Facial shape deformation (HP:0011334) | 3.90012607 |
| 25 | Ketosis (HP:0001946) | 3.86455677 |
| 26 | Hepatocellular necrosis (HP:0001404) | 3.78011787 |
| 27 | Hyperglycinemia (HP:0002154) | 3.77667165 |
| 28 | Methylmalonic aciduria (HP:0012120) | 3.73839089 |
| 29 | Nausea (HP:0002018) | 3.71334830 |
| 30 | Abnormality of alanine metabolism (HP:0010916) | 3.71013488 |
| 31 | Hyperalaninemia (HP:0003348) | 3.71013488 |
| 32 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.71013488 |
| 33 | Skin nodule (HP:0200036) | 3.68521997 |
| 34 | Infantile muscular hypotonia (HP:0008947) | 3.65774160 |
| 35 | Tubulointerstitial fibrosis (HP:0005576) | 3.64199365 |
| 36 | Abnormality of glycolysis (HP:0004366) | 3.63519061 |
| 37 | Increased serum pyruvate (HP:0003542) | 3.63519061 |
| 38 | Hypercholesterolemia (HP:0003124) | 3.60329840 |
| 39 | Acute encephalopathy (HP:0006846) | 3.59409839 |
| 40 | Limb hypertonia (HP:0002509) | 3.53781988 |
| 41 | Impulsivity (HP:0100710) | 3.48518334 |
| 42 | Acanthosis nigricans (HP:0000956) | 3.46932812 |
| 43 | Hypertriglyceridemia (HP:0002155) | 3.45940573 |
| 44 | Increased variability in muscle fiber diameter (HP:0003557) | 3.43758757 |
| 45 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.41298345 |
| 46 | Cerebral edema (HP:0002181) | 3.38994836 |
| 47 | Lactic acidosis (HP:0003128) | 3.38977815 |
| 48 | Myocardial infarction (HP:0001658) | 3.36171215 |
| 49 | Proximal tubulopathy (HP:0000114) | 3.30754599 |
| 50 | Exercise-induced myalgia (HP:0003738) | 3.16623599 |
| 51 | Lethargy (HP:0001254) | 3.16348826 |
| 52 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.12558492 |
| 53 | Cerebral inclusion bodies (HP:0100314) | 3.11278552 |
| 54 | Increased intramyocellular lipid droplets (HP:0012240) | 3.10778186 |
| 55 | Acute necrotizing encephalopathy (HP:0006965) | 3.08810397 |
| 56 | Conjunctival hamartoma (HP:0100780) | 3.08639822 |
| 57 | Pheochromocytoma (HP:0002666) | 3.04941946 |
| 58 | Difficulty running (HP:0009046) | 3.04928868 |
| 59 | Bone cyst (HP:0012062) | 3.04199002 |
| 60 | Methylmalonic acidemia (HP:0002912) | 2.94656835 |
| 61 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.93285840 |
| 62 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.93285840 |
| 63 | Long foot (HP:0001833) | 2.92432367 |
| 64 | Muscle stiffness (HP:0003552) | 2.90899451 |
| 65 | Increased CSF lactate (HP:0002490) | 2.89191379 |
| 66 | Back pain (HP:0003418) | 2.88959875 |
| 67 | Lipid accumulation in hepatocytes (HP:0006561) | 2.83436692 |
| 68 | Premature rupture of membranes (HP:0001788) | 2.79866508 |
| 69 | Respiratory failure (HP:0002878) | 2.76386738 |
| 70 | Athetosis (HP:0002305) | 2.75688214 |
| 71 | Abnormality of serum amino acid levels (HP:0003112) | 2.72896402 |
| 72 | Abnormal hemoglobin (HP:0011902) | 2.71497205 |
| 73 | Progressive macrocephaly (HP:0004481) | 2.70780393 |
| 74 | Neonatal death (HP:0003811) | 2.65709534 |
| 75 | Hemorrhage of the eye (HP:0011885) | 2.64277797 |
| 76 | Neuroendocrine neoplasm (HP:0100634) | 2.64184127 |
| 77 | Neoplasm of head and neck (HP:0012288) | 2.61062826 |
| 78 | Esophageal neoplasm (HP:0100751) | 2.61062826 |
| 79 | Vomiting (HP:0002013) | 2.59594209 |
| 80 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.59096528 |
| 81 | Buphthalmos (HP:0000557) | 2.58265253 |
| 82 | Mitochondrial inheritance (HP:0001427) | 2.56389386 |
| 83 | Tachypnea (HP:0002789) | 2.56140811 |
| 84 | Facial diplegia (HP:0001349) | 2.55161818 |
| 85 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.53237225 |
| 86 | Metabolic acidosis (HP:0001942) | 2.52205610 |
| 87 | Mesangial abnormality (HP:0001966) | 2.49505032 |
| 88 | Cerebral hemorrhage (HP:0001342) | 2.46366843 |
| 89 | Polyphagia (HP:0002591) | 2.45462276 |
| 90 | Tubulointerstitial abnormality (HP:0001969) | 2.44867553 |
| 91 | Neurofibrillary tangles (HP:0002185) | 2.44039516 |
| 92 | Subcapsular cataract (HP:0000523) | 2.39629175 |
| 93 | Hamartoma of the eye (HP:0010568) | 2.36657121 |
| 94 | Protrusio acetabuli (HP:0003179) | 2.28693442 |
| 95 | Reduced antithrombin III activity (HP:0001976) | 2.22853197 |
| 96 | Large hands (HP:0001176) | 2.21368565 |
| 97 | Megalocornea (HP:0000485) | 2.20776457 |
| 98 | Upper motor neuron abnormality (HP:0002127) | 2.18857168 |
| 99 | Ectopia lentis (HP:0001083) | 2.16536162 |
| 100 | Coronal craniosynostosis (HP:0004440) | 2.16347031 |
| 101 | Growth hormone excess (HP:0000845) | 2.15292179 |
| 102 | Renal Fanconi syndrome (HP:0001994) | 2.14536742 |
| 103 | Exertional dyspnea (HP:0002875) | 2.13867025 |
| 104 | Type II lissencephaly (HP:0007260) | 2.13568052 |
| 105 | Opisthotonus (HP:0002179) | 2.13534440 |
| 106 | Neonatal onset (HP:0003623) | 2.13510573 |
| 107 | Abnormality of abdominal situs (HP:0011620) | 2.09139132 |
| 108 | Abdominal situs inversus (HP:0003363) | 2.09139132 |
| 109 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.08894835 |
| 110 | Pachygyria (HP:0001302) | 2.07917909 |
| 111 | Hypoglycemic seizures (HP:0002173) | 2.07539902 |
| 112 | Vertebral compression fractures (HP:0002953) | 2.05999959 |
| 113 | Pigmentary retinal degeneration (HP:0001146) | 2.05186108 |
| 114 | Vertebral hypoplasia (HP:0008417) | 2.04084473 |
| 115 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.04084473 |
| 116 | Abnormal social behavior (HP:0012433) | 2.03547919 |
| 117 | Impaired social interactions (HP:0000735) | 2.03547919 |
| 118 | Prominent supraorbital ridges (HP:0000336) | 2.03376466 |
| 119 | Exercise intolerance (HP:0003546) | 2.03110525 |
| 120 | Prenatal maternal abnormality (HP:0002686) | 2.02853152 |
| 121 | Axonal loss (HP:0003447) | 2.01239468 |
| 122 | Stridor (HP:0010307) | 2.00308991 |
| 123 | Insulin resistance (HP:0000855) | 2.00128323 |
| 124 | Increased connective tissue (HP:0009025) | 1.99656986 |
| 125 | Pancreatitis (HP:0001733) | 1.98616620 |
| 126 | Hepatosplenomegaly (HP:0001433) | 1.98491084 |
| 127 | Increased serum lactate (HP:0002151) | 1.98166999 |
| 128 | Multiple enchondromatosis (HP:0005701) | 1.97588410 |
| 129 | Abnormality of the renal cortex (HP:0011035) | 1.96976008 |
| 130 | Hypoalphalipoproteinemia (HP:0003233) | 1.96162493 |
| 131 | Respiratory distress (HP:0002098) | 1.95113595 |
| 132 | Abnormality of purine metabolism (HP:0004352) | 1.94874754 |
| 133 | Neonatal hypoglycemia (HP:0001998) | 1.94723747 |
| 134 | Neoplasm of the adrenal gland (HP:0100631) | 1.94637780 |
| 135 | Tetraparesis (HP:0002273) | 1.94456620 |
| 136 | Abnormal glucose tolerance (HP:0001952) | 1.91432091 |
| 137 | Dilated cardiomyopathy (HP:0001644) | 1.90802673 |
| 138 | Delayed CNS myelination (HP:0002188) | 1.90446495 |
| 139 | Elevated hepatic transaminases (HP:0002910) | 1.87967205 |
| 140 | Frequent falls (HP:0002359) | 1.86439269 |
| 141 | Sudden death (HP:0001699) | 1.84311044 |
| 142 | Dysmetric saccades (HP:0000641) | 1.84057285 |
| 143 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.83098470 |
| 144 | Gliosis (HP:0002171) | 1.82757967 |
| 145 | Renal tubular dysfunction (HP:0000124) | 1.81939902 |
| 146 | Ankle contracture (HP:0006466) | 1.79392449 |
| 147 | Ileus (HP:0002595) | 1.79205012 |
| 148 | Abnormal cartilage morphology (HP:0002763) | 1.79064706 |
| 149 | Lipoatrophy (HP:0100578) | 1.78983739 |
| 150 | Abnormality of the periventricular white matter (HP:0002518) | 1.78522132 |
| 151 | Acute hepatic failure (HP:0006554) | 1.77894032 |
| 152 | Renal tubular acidosis (HP:0001947) | 1.76054919 |
| 153 | Palpitations (HP:0001962) | 1.76050485 |
| 154 | Wide anterior fontanel (HP:0000260) | 1.75276885 |
| 155 | Glycosuria (HP:0003076) | 1.75133009 |
| 156 | Abnormality of urine glucose concentration (HP:0011016) | 1.75133009 |
| 157 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.71932184 |
| 158 | Abnormality of the basal ganglia (HP:0002134) | 1.67636956 |
| 159 | Ragged-red muscle fibers (HP:0003200) | 1.67289398 |
| 160 | CNS demyelination (HP:0007305) | 1.66740770 |
| 161 | Hyperglycemia (HP:0003074) | 1.64481977 |
| 162 | Delayed gross motor development (HP:0002194) | 1.63966157 |
| 163 | Abnormality of vision evoked potentials (HP:0000649) | 1.63518863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 6.22438798 |
| 2 | BCKDK | 6.22023275 |
| 3 | PDK4 | 6.11709116 |
| 4 | PDK3 | 6.11709116 |
| 5 | TRIB3 | 4.89801972 |
| 6 | CAMK1G | 4.48778853 |
| 7 | PDK2 | 3.91307977 |
| 8 | SIK1 | 2.75345126 |
| 9 | PRKAA2 | 2.10920256 |
| 10 | MAP2K7 | 2.09222866 |
| 11 | MAP3K4 | 1.92726827 |
| 12 | EPHA3 | 1.70396150 |
| 13 | DAPK3 | 1.52163108 |
| 14 | PIM2 | 1.47578770 |
| 15 | INSRR | 1.45501043 |
| 16 | CDK9 | 1.42957489 |
| 17 | PDPK1 | 1.40590781 |
| 18 | MAP2K4 | 1.38088466 |
| 19 | MYLK | 1.31685862 |
| 20 | PRKD3 | 1.30853772 |
| 21 | LATS1 | 1.21527363 |
| 22 | PDK1 | 1.19715916 |
| 23 | TIE1 | 1.19634781 |
| 24 | TYRO3 | 1.14539390 |
| 25 | PRKAA1 | 1.08945970 |
| 26 | RIPK1 | 1.07595582 |
| 27 | PKN2 | 1.04726343 |
| 28 | PDGFRA | 1.04145132 |
| 29 | NLK | 0.98435414 |
| 30 | PINK1 | 0.97466519 |
| 31 | CDK3 | 0.96167961 |
| 32 | PRKCH | 0.95984217 |
| 33 | ERN1 | 0.94206936 |
| 34 | MAP3K5 | 0.93756155 |
| 35 | TGFBR2 | 0.91616911 |
| 36 | TESK1 | 0.91180287 |
| 37 | CDK6 | 0.89323753 |
| 38 | LATS2 | 0.87294411 |
| 39 | SGK2 | 0.86893685 |
| 40 | MARK1 | 0.83830639 |
| 41 | MAP2K1 | 0.81639825 |
| 42 | PAK2 | 0.81463208 |
| 43 | DYRK3 | 0.78522969 |
| 44 | DYRK1B | 0.77904930 |
| 45 | PRKACG | 0.72354246 |
| 46 | MAP3K6 | 0.71607789 |
| 47 | JAK1 | 0.70420924 |
| 48 | FGFR3 | 0.68377479 |
| 49 | TTN | 0.68204054 |
| 50 | MAPK3 | 0.68051795 |
| 51 | LMTK2 | 0.66620539 |
| 52 | FGFR2 | 0.64551676 |
| 53 | EPHB1 | 0.63865050 |
| 54 | PTK2 | 0.63573149 |
| 55 | MST1R | 0.60548685 |
| 56 | CDK4 | 0.59329920 |
| 57 | NTRK3 | 0.58910394 |
| 58 | PRPF4B | 0.58637542 |
| 59 | DYRK2 | 0.56900233 |
| 60 | MTOR | 0.56453130 |
| 61 | CAMK1 | 0.56352179 |
| 62 | TAOK1 | 0.54417688 |
| 63 | STK16 | 0.52175370 |
| 64 | CLK1 | 0.51785170 |
| 65 | STK38L | 0.51764703 |
| 66 | MAP2K3 | 0.51659030 |
| 67 | FRK | 0.49900803 |
| 68 | FGFR4 | 0.48719828 |
| 69 | ICK | 0.47306569 |
| 70 | ABL2 | 0.46485550 |
| 71 | ILK | 0.46381090 |
| 72 | GSK3A | 0.45835326 |
| 73 | PRKG1 | 0.45697074 |
| 74 | PRKD1 | 0.45059376 |
| 75 | ROCK1 | 0.43477433 |
| 76 | MAPK11 | 0.43456908 |
| 77 | STK3 | 0.43396511 |
| 78 | SGK3 | 0.42848276 |
| 79 | PIK3CA | 0.42690834 |
| 80 | NEK9 | 0.42154167 |
| 81 | WNK1 | 0.41683303 |
| 82 | STK11 | 0.41145031 |
| 83 | CAMKK1 | 0.38753498 |
| 84 | CDC42BPA | 0.38555244 |
| 85 | JAK2 | 0.38457557 |
| 86 | FLT3 | 0.37450364 |
| 87 | PRKD2 | 0.37402593 |
| 88 | CASK | 0.37157632 |
| 89 | TYK2 | 0.37100067 |
| 90 | EPHB2 | 0.36074717 |
| 91 | PDGFRB | 0.35761147 |
| 92 | RET | 0.35527808 |
| 93 | IGF1R | 0.34301250 |
| 94 | EIF2AK2 | 0.34087914 |
| 95 | INSR | 0.33257564 |
| 96 | PAK6 | 0.32966949 |
| 97 | AKT2 | 0.32058657 |
| 98 | PRKCE | 0.31902894 |
| 99 | IRAK3 | 0.31888764 |
| 100 | MAPK13 | 0.31609428 |
| 101 | MAPK1 | 0.31468651 |
| 102 | CAMK4 | 0.31416253 |
| 103 | RPS6KA2 | 0.30628497 |
| 104 | JAK3 | 0.28934730 |
| 105 | MAPK4 | 0.28783733 |
| 106 | PAK1 | 0.28694866 |
| 107 | PHKG2 | 0.28424942 |
| 108 | PHKG1 | 0.28424942 |
| 109 | NTRK1 | 0.27518666 |
| 110 | RPS6KB1 | 0.27001476 |
| 111 | PKN1 | 0.26576332 |
| 112 | SGK223 | 0.25669968 |
| 113 | SGK494 | 0.25669968 |
| 114 | KSR2 | 0.25528487 |
| 115 | GRK5 | 0.24165325 |
| 116 | PTK2B | 0.22581216 |
| 117 | CDK5 | 0.22451802 |
| 118 | MARK2 | 0.20399062 |
| 119 | BMX | 0.20035977 |
| 120 | PRKG2 | 0.19180657 |
| 121 | AKT1 | 0.18906299 |
| 122 | PRKACA | 0.18489691 |
| 123 | IRAK2 | 0.18097418 |
| 124 | CAMKK2 | 0.17622301 |
| 125 | PTK6 | 0.17349541 |
| 126 | RPS6KA3 | 0.16700612 |
| 127 | IRAK1 | 0.16219518 |
| 128 | DDR2 | 0.16183395 |
| 129 | MAPK12 | 0.15993881 |
| 130 | SGK1 | 0.15802523 |
| 131 | MET | 0.15101342 |
| 132 | STK38 | 0.13368445 |
| 133 | SRC | 0.12695300 |
| 134 | FGFR1 | 0.11156730 |
| 135 | NEK1 | 0.11022043 |
| 136 | KDR | 0.10432345 |
| 137 | PRKCZ | 0.10342287 |
| 138 | MAPK8 | 0.10093360 |
| 139 | MAP3K2 | 0.09495907 |
| 140 | CSNK1G1 | 0.08368147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.72648553 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 5.74692442 |
| 3 | Fatty acid metabolism_Homo sapiens_hsa01212 | 4.66155317 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 4.60589621 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 4.08646716 |
| 6 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.90040583 |
| 7 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.48360406 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.97700758 |
| 9 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 2.95816320 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.81097262 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.70458405 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.66399936 |
| 13 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.08257368 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.97848009 |
| 15 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.87460296 |
| 16 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.57601547 |
| 17 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.55697652 |
| 18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.45394732 |
| 19 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.41147259 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 1.39784954 |
| 21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.36302818 |
| 22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.31873548 |
| 23 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.28446323 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.25957664 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.25496911 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.23300665 |
| 27 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.20591962 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.13718230 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.09425773 |
| 30 | Insulin resistance_Homo sapiens_hsa04931 | 1.02484431 |
| 31 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98163963 |
| 32 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.94986597 |
| 33 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91822659 |
| 34 | Lysine degradation_Homo sapiens_hsa00310 | 0.91349794 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84165903 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79925165 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77631216 |
| 38 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.76208451 |
| 39 | Huntingtons disease_Homo sapiens_hsa05016 | 0.74248677 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72388615 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71445450 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64186028 |
| 43 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63803669 |
| 44 | Histidine metabolism_Homo sapiens_hsa00340 | 0.62713934 |
| 45 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60827159 |
| 46 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60804644 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57728377 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.49736093 |
| 49 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49241654 |
| 50 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47591543 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46620369 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.44946569 |
| 53 | Renin secretion_Homo sapiens_hsa04924 | 0.42844459 |
| 54 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37963608 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.36231607 |
| 56 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35837711 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.34350449 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.32639054 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 0.30576602 |
| 60 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25448692 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.25085090 |
| 62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.24438013 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.23730035 |
| 64 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.23659921 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.22474742 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.22360786 |
| 67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.21981604 |
| 68 | Salivary secretion_Homo sapiens_hsa04970 | 0.19885948 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18598770 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.18089061 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.17557767 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.17084032 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.13780794 |
| 74 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.12307686 |
| 75 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.11753144 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.09445069 |
| 77 | Cocaine addiction_Homo sapiens_hsa05030 | 0.09168854 |
| 78 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.08390498 |
| 79 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.07903694 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.06920399 |
| 81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.06790136 |
| 82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.06368810 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.06000409 |
| 84 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.05855422 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.05084944 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.04362635 |
| 87 | Bile secretion_Homo sapiens_hsa04976 | 0.03201052 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.03148653 |
| 89 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.03060481 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.01982525 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.01541691 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1387170 |
| 93 | Melanogenesis_Homo sapiens_hsa04916 | -0.1333575 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1311861 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | -0.1252744 |
| 96 | Dopaminergic synapse_Homo sapiens_hsa04728 | -0.1075301 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | -0.1015467 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0955975 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | -0.0954251 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | -0.0952675 |
| 101 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0901724 |
| 102 | Gap junction_Homo sapiens_hsa04540 | -0.0899483 |
| 103 | Arginine biosynthesis_Homo sapiens_hsa00220 | -0.0893995 |
| 104 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | -0.0834711 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.0824446 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | -0.0822364 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | -0.0770156 |
| 108 | Viral myocarditis_Homo sapiens_hsa05416 | -0.0761800 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | -0.0749160 |
| 110 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | -0.0734740 |
| 111 | Morphine addiction_Homo sapiens_hsa05032 | -0.0715928 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0711758 |
| 113 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | -0.0708388 |
| 114 | Glutathione metabolism_Homo sapiens_hsa00480 | -0.0703375 |
| 115 | Gastric acid secretion_Homo sapiens_hsa04971 | -0.0656964 |
| 116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0590399 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0587468 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | -0.0555149 |
| 119 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0434175 |
| 120 | Chemical carcinogenesis_Homo sapiens_hsa05204 | -0.0407804 |
| 121 | Platelet activation_Homo sapiens_hsa04611 | -0.0367768 |
| 122 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0362442 |
| 123 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | -0.0252765 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0221618 |
| 125 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | -0.0182454 |
| 126 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0181115 |
| 127 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | -0.0148217 |
| 128 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | -0.0144759 |
| 129 | Focal adhesion_Homo sapiens_hsa04510 | -0.0092927 |
| 130 | cAMP signaling pathway_Homo sapiens_hsa04024 | -0.0074609 |
| 131 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.0012611 |
| 132 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | -0.0002109 |

